What midlife blood pressure, diabetes and smoking cost you in dementia-free years

Short answer: About thirteen years. In a study of 12,409 adults followed for roughly 26 years, people who reached middle age with none of three conditions — high blood pressure, type 2 diabetes and smoking — averaged 30.1 dementia-free years from age 55 onward. People with all three averaged 17.5. That gap is the clearest picture yet of what midlife vascular health buys you, and it's measured in something more useful than a risk percentage: time. The study is observational, so it shows association rather than proof of cause. But these three factors are also the ones most within reach.

This is educational, not medical advice. Blood pressure, blood sugar and stopping smoking are all things to work on with your doctor — especially if medication is involved. Don't start, stop or change any treatment based on an article.

The study, and what makes it different

Most dementia research hands you a hazard ratio: your risk is 1.6 times higher, 40% elevated, and so on. Those numbers are hard to feel. Is a 40% higher risk of something that might happen in thirty years worth changing your Tuesday for?

A study published in Neurology Open Access on 5 August 2026 asked the question differently. Instead of "how much does your risk go up?", it asked "how many years do you get without dementia?"

The researchers used the Atherosclerosis Risk in Communities (ARIC) study — a community cohort running since 1986 — and followed 12,409 adults who were free of dementia, with a mean age of 56, for an average of 26 years. Over that time, 3,008 people developed dementia and 5,238 died without ever developing it. They looked at three midlife vascular risk factors: high blood pressure, type 2 diabetes, and smoking. Then they calculated dementia-free survival years from age 55.

The headline result — and note that it's a clean dose-response, not just a best-versus-worst comparison:

A difference of roughly 12.6 years between the ends — and each factor appears to cost something on its own. Compared with people who had none, those with all three had 2.69 times the hazard of dementia (95% CI 1.94–3.73).

That gradient matters more than the headline. It means this isn't all-or-nothing: getting one factor under control is worth something even if the others remain.

Why "years" is the more honest number

There's a reason we think this framing matters, and it isn't just that it sounds better.

A risk percentage invites a question nobody can answer: does that mean me? It can't be verified in your own life, which is why it so easily becomes either panic or a shrug.

Dementia-free years describes something different: not whether, but when. For a great many people, dementia risk isn't eliminated by anything — it's pushed back. And pushing it back is not a lesser prize. Thirteen additional years of independent living, of recognising your family, of making your own decisions, is a large fraction of a retirement.

This is also why we won't show you a personal risk percentage anywhere in our product. We can't compute one honestly, and neither can anyone else selling you a number. What research like this supports is a population-level statement about the factors that shift the odds — not a prediction about your life. The 30-versus-17.5 contrast above is a description of a cohort, not a forecast for any individual in it, including you.

The part the headlines left out

There's a detail buried in this study that almost no coverage mentioned, and leaving it out would make the number above misleading.

People with all three risk factors developed dementia earlier. But their lifetime cumulative incidence of dementia by age 95 was actually lower — about 23%, versus 42% for those with no risk factors.

That sounds like a contradiction. It isn't. It's because they were substantially more likely to die first. Compared with people who had none of the three, those with all three had 5.61 times the hazard of death without dementia (95% CI 4.67–6.74) — a far larger effect than the 2.69-fold hazard for dementia itself.

So the honest reading of "13 more dementia-free years" is this: high blood pressure, diabetes and smoking in midlife are associated both with getting dementia sooner and with dying sooner. The extra dementia-free years in the healthy group are real years of life, not a statistical trick — but the reason the worst-off group doesn't show more dementia over a full lifespan is that many of them don't live long enough to develop it.

This is called competing risk, and it's why "lifetime risk of dementia" can be a deceptive number in isolation. It's also why we'd rather show you years than a percentage. Nothing here suggests that keeping your blood pressure high is a strategy — the same three factors drive cardiovascular death, which is what the 5.61 figure is describing.

What the study found about who is affected

Two breakdowns in the data deserve care, because they're easy to report badly. Among people carrying all three risk factors:

• Women averaged 18.1 dementia-free years; men 16.6.
• White participants averaged 19.6 dementia-free years; Black participants 16.0.

The study also found that APOE-ε4 carriers had fewer dementia-free years than non-carriers — genetics and vascular health both showing up in the same dataset. That's worth knowing, and it's not a reason for fatalism: as we cover in should you get an APOE gene test?, randomised-trial evidence suggests ε4 carriers may benefit more than non-carriers from working on exactly these modifiable factors.

The racial difference is not a statement about biology or about anyone's personal risk. Cohorts like ARIC consistently show that differences of this kind track access to care, how early hypertension and diabetes are detected and treated, and the cumulative effects of unequal treatment over decades — the same vascular factors, caught later and controlled less well. Read it as a finding about healthcare systems, which is how the researchers frame it, and as an argument for earlier detection where it's currently happening latest. It says nothing about what any individual reader should expect.

Why midlife specifically

The study centres on roughly ages 48 to 68, and that isn't arbitrary.

That window is when high blood pressure and type 2 diabetes most commonly first appear — and the vascular damage they cause is cumulative. Two decades of slightly elevated blood pressure does quiet, additive damage to the small vessels feeding the brain. By the time symptoms of cognitive decline appear, typically in the seventies or eighties, much of that damage is long since done.

Which is the uncomfortable and genuinely useful implication: the period when these factors matter most is the period when they cause you no symptoms at all. High blood pressure feels like nothing. Early type 2 diabetes feels like nothing. That's precisely the trap — the years when acting pays the largest dividend are the years when nothing is prompting you to act.

We've written in more depth about each of these: blood pressure and dementia and blood sugar, type 2 diabetes and your dementia risk.

How this fits the wider evidence

This result doesn't stand alone, which is what makes it credible.

• The 2024 Lancet Commission identified 14 modifiable risk factors that together account for around 45% of dementia cases worldwide — hypertension, diabetes and smoking among them (our guide).
• The WHO's 2026 risk-reduction guidelines put the same vascular cluster at the centre of their recommendations (what changed).
• US POINTER (JAMA, July 2025) showed in a randomised trial of 2,111 adults that a structured multidomain programme improved global cognition more than a self-guided one — evidence that acting on these factors in an organised way changes outcomes, not just associations.

So: three independent lines — a large observational cohort, an international evidence review, and a randomised trial — pointing at the same short list. That convergence is the real story here.

What the study can't tell you

Being straight about the limits, as the authors are:

• It's observational. It shows association, not proof that avoiding these three factors causes the extra years. People without hypertension, diabetes or a smoking habit in midlife differ in other ways too.
• The risk factors were measured once. The study didn't capture people who quit smoking at 60, or who got their blood pressure under control at 58. That's a real limitation — and note which direction it cuts: if anything, treating a single midlife snapshot as fixed would tend to blur the contrast rather than invent it.
• It doesn't establish a treatment effect. It does not show that starting a blood pressure medication at 55 buys you thirteen years. Trials, not cohorts, answer that question — and on blood pressure specifically, SPRINT-MIND found that targeting a systolic pressure below 120 rather than below 140 significantly reduced mild cognitive impairment, with a smaller, non-significant reduction in dementia itself.

None of that undermines the finding. It just means the honest reading is: these three factors are strongly associated with how long people live without dementia, and they're also the three most clearly worth discussing with your doctor.

What to actually do with this

None of the three is exotic, and that's the point.

Know your blood pressure numbers. Not "it was fine a few years ago" — an actual recent reading. It's the single most consequential number in this list and the one most likely to be silently drifting.

Know your HbA1c or fasting glucose. Type 2 diabetes is often present for years before diagnosis, and prediabetes is a live window for change.

If you smoke, stopping still counts in midlife. Smoking is on every major risk list, and quitting is the highest-yield single change available to most people who do it. Ask your clinician what support is available — the structured options work considerably better than willpower alone.

Then keep going. The factors in this study interact with the rest: hearing, sleep, activity, alcohol, social connection. Consistency across several small levers beats perfection on one.

How we research and review our content →

This article is educational and is not medical advice, diagnosis, or treatment. The ARIC analysis described here is observational: it shows associations between midlife vascular risk factors and dementia-free survival, and does not establish that avoiding those factors causes additional dementia-free years. Its authors note that risk factors were measured only once and that changes over time were not captured. Figures describe a study population, not any individual, and are not a prediction for you. Differences reported between demographic groups reflect population-level patterns shaped by access to care and social factors, and say nothing about an individual's risk. Solenna is not a medical device and does not diagnose, prevent, treat, or cure Alzheimer's disease or any other condition. Risk reduction means lowering probability, not eliminating it; individual results vary and no outcome is guaranteed. Do not start, stop, or change any medication on the basis of this article — speak with a qualified healthcare professional.